Fifteen new synthetic opioids and 5 other drugs will be banned as Class A drugs as the government continues to act to prevent drug deaths.
Advisory Council On The Misuse Of Drugs
Latest Government News
- Press release: £100m for vulnerable countries tackling climate change
- Guidance: River Thames: current river conditions
- Transparency data: Migrants detected crossing the English Channel in small boats
- Press release: Health and Social Care Secretary sets out priorities for system
- Press release: £100m for vulnerable countries tackling climate change
- Press release: UK military activity in the Eastern Mediterranean
- Fatality notice: Ministry of Defence confirms the death of Major Kevin McCool
- Guidance: River Thames: current river conditions
- Transparency data: Migrants detected crossing the English Channel in small boats
- Press release: UK powers up partnership with US and Australia to strengthen security
Monday, 27 November 2023
Friday, 17 November 2023
The Advisory Council on the Misuse of Drugs call for evidence, collecting written evidence to better understand internet-facilitated drug markets (IFDMs).
Tuesday, 24 October 2023
Report from the Advisory Council on the Misuse of Drugs (ACMD) on consumer cannabidiol (CBD) products.
Monday, 23 October 2023
The government responds to a report by the Advisory Council on the Misuse of Drugs and commissions Part 2 of work on barriers to research.
Wednesday, 18 October 2023
A review of the evidence on the use and harms of 2-benzyl benzimidazole (nitazene) and piperidine benzimidazolone (brorphine-like) opioids.
Friday, 06 October 2023
A review of the evidence on the use and harms of 2-benzyl benzimidazole (nitazene) and piperidine benzimidazolone (brorphine-like) opioids.
Tuesday, 26 September 2023
The Advisory Council on the Misuse of Drugs has undertaken a review of the availability and implementation of naloxone in the UK.
Thursday, 21 September 2023
The ACMD will use your response to help them formulate advice to government about drug use in ethnic minority groups.
Tuesday, 05 September 2023
The Advisory Council on the Misuse of Drugs (ACMD) has provided advice on the scheduling of nitrous oxide.
Monday, 04 September 2023
The Home Secretary has today announced the reappointment of Professor Owen Bowden-Jones as the chair of the ACMD.
Wednesday, 30 August 2023
Call for evidence from the Advisory Council on the Misuse of Drugs on the prevalence and drivers of powder cocaine use by young people and adults.
Friday, 11 August 2023
The Advisory Council on the Misuse of Drugs (ACMD) has provided advice on the scheduling of nitrous oxide.
Wednesday, 02 August 2023
The Home Office is looking for 16 new members to join the Advisory Council on the Misuse of Drugs (ACMD).
Thursday, 27 July 2023
Letter commissioning the Advisory Council on the Misuse of Drugs (ACMD) to work on a project to prevent drug use in children and young people.
Thursday, 27 July 2023
Call for evidence from the Advisory Council on the Misuse of Drugs on the prevalence and drivers of powder cocaine use by young people and adults.
Tuesday, 25 July 2023
Government response to the ACMD's review of the evidence on the use and harms of Cumyl-PeGaClone.
Tuesday, 25 July 2023
Government response to the ACMD's review of the evidence on the use and harms of Cumyl-PeGaClone.
Tuesday, 25 July 2023
Government response to the ACMD's review of the evidence on the use and harms of Cumyl-PeGaClone.
Monday, 03 July 2023
Letter from the Advisory Council on the Misuse of Drugs (ACMD) regarding electronic prescribing of controlled drugs proposal from NHS England.
Friday, 30 June 2023
Letter from the Advisory Council on the Misuse of Drugs (ACMD) regarding electronic prescribing of controlled drugs proposal from NHS England.
Thursday, 22 June 2023
This report provides an updated assessment of the health and social harms of nitrous oxide.
Tuesday, 20 June 2023
This report provides an updated assessment of the health and social harms of nitrous oxide.
Friday, 16 June 2023
This report provides an updated assessment of the health and social harms of nitrous oxide.
Thursday, 08 June 2023
The Advisory Council on the Misuse of Drugs has undertaken a review of the evidence on the use and harms of Cumyl-PeGaClone.
Friday, 26 May 2023
The Advisory Council on the Misuse of Drugs has undertaken a review of the evidence on the use and harms of diphenidine and other related substances.
Thursday, 25 May 2023
The Advisory Council on the Misuse of Drugs has undertaken a review of the evidence on the use and harms of diphenidine and other related substances.
Thursday, 25 May 2023
The Advisory Council on the Misuse of Drugs has undertaken a review of the evidence on the use and harms of Cumyl-PeGaClone.
Thursday, 11 May 2023
The government commissions the ACMD to conduct an updated harms assessment of synthetic cathinones.
Monday, 27 March 2023
This report provides an updated assessment of the health and social harms of nitrous oxide.
Tuesday, 07 March 2023
This report provides an updated assessment of the health and social harms of nitrous oxide.
Monday, 06 March 2023
The Advisory Council on the Misuse of Drugs (ACMD) has today (6 March 2023) published an updated harms assessment of nitrous oxide.
Monday, 06 March 2023
The Advisory Council on the Misuse of Drugs (ACMD) has today (6 March 2023) published an updated harms assessment of nitrous oxide.
Monday, 06 March 2023
This report provides an updated assessment of the health and social harms of nitrous oxide.
Wednesday, 08 February 2023
Letter from the ACMD Nitrous Oxide working group to collect written evidence about the health and social harms of nitrous oxide.
Tuesday, 07 February 2023
Letter to the chair of the ACMD asking the council to conduct an updated assessment of the health and social harms of nitrous oxide.
Friday, 03 February 2023
A review of the evidence on the use and harms of 2-benzyl benzimidazole (nitazene) and piperidine benzimidazolone (brorphine-like) opioids.
Monday, 19 December 2022
A review of the evidence on the use and harms of 2-benzyl benzimidazole (nitazene) and piperidine benzimidazolone (brorphine-like) opioids.
Monday, 12 December 2022
Recommendations to reduce barriers to research, using compounds described by the third generation synthetic cannabinoid receptor agonists generic definition.
Monday, 12 December 2022
The government responds to a report by the Advisory Council on the Misuse of Drugs and commissions Part 2 of work on barriers to research.
Friday, 09 December 2022
Letter from the Advisory Council on the Misuse of Drugs (ACMD) on young people’s drug use.
Friday, 09 December 2022
Letter from the Advisory Council on the Misuse of Drugs (ACMD) on young people’s drug use.
Tuesday, 06 December 2022
This report provides an updated harms assessment to the ACMD's previous reports on synthetic cannabinoid receptor agonists.
Friday, 02 December 2022
Report from the Advisory Council on the Misuse of Drugs (ACMD) on the classification and schedule of Remimazolam.
Monday, 03 October 2022
Letter from ACMD to ministers, providing advice on the administration rights of morphine by injection for therapeutic radiographer independent prescribers.
Monday, 03 October 2022
Letter from Advisory Council on the Misuse of Drugs (ACMD) to ministers, providing advice on independent prescribing of controlled drugs by paramedics.
Ministerial Departmental News
- PM's Office, 10 Downing Street
- Cabinet Office
- Department for Business, Innovation and Skills
- Department for Communities and Local Government
- Department for Culture, Media and Sport
- Department for Education
- Department for Environment, Food and Rural Affairs
- Department for International Development
- Department for Transport
- Department for Work and Pensions
- Department of Energy and Climate Change
- Department of Health
- Foreign and Commonwealth Office
- HM Treasury
- Home Office
- Ministry of Defence
- Ministry of Justice
- Northern Ireland Office
- Scotland Office
- Wales Office
- See all departments